Read the original article at www.BrownDailyHerald.com (part of a special Metro Section on Providence’s “Knowledge Economy”) Vaccination Equation: The Search Goes On Brian Mastroianni Features Editor Published: Thursday, March 11, 2010 Updated: Sunday, March 14, 2010 Situated across from a parking lot, the two-story grayish-brown building at 146 Clifford Street is an unimposing site, nestled in the heart of Providence’s Jewelry District. ...

Read the original article at www.BrownDailyHerald.com (part of a special Metro Section on Providence’s “Knowledge Economy”) Vaccination Equation: The Search Goes On Brian Mastroianni Features Editor Published: Thursday, March 11, 2010 Updated: Sunday, March 14, 2010 Situated across from a parking lot, the two-story grayish-brown building at 146 Clifford Street is an unimposing site, nestled in the heart of Providence’s Jewelry District. ...

View Press Release as PDF DECEMBER 1, 2009, Providence, RI EpiVax, Inc. today announced a collaborative research agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) aimed at evaluating EpiVax’s proprietary Tregitope technology, which could potentially reduce detrimental immune responses to certain drugs. In the course of the Roche-EpiVax collaboration, the EpiVax Tregitope technology will be evaluated for ...

Read the article at projo.com Providence’s Jewelry District: Growth hotspot? 01:00 AM EST on Saturday, November 14, 2009 By Philip Marcelo Journal Staff Writer PROVIDENCE — U.S. Rep. David R. Obey, chairman of the House Appropriations Committee, toured four major research institutions in the city’s Jewelry District on Friday along with Rep. Patrick J. Kennedy, ...

Read article at URI website URI biotech student awarded Fearless Scientist Scholarship by Institute for Immunology & Informatics Media Contact: Todd McLeish, 401-874-2116 PROVIDENCE, R.I. – November 4, 2009 – During a nearly 30-year career, Cranston resident Kathy Vachon has operated a foot press, sold insurance, worked as a diet aide at a nursing home, been a ...

By Helen Graves Read article at BostonHerald.com It’s a wonder, but yet no surprise, that Annie De Groot, EpiVax founder, CEO and CSO, is pioneering new fields in infectious and autoimmune diseases while also paying attention to the least served – and doing so in so many ways. “What explains my life is: Stop talking and start acting,” ...

MTC 594 – Special Problems in Biotechnology Topic: Development of Vaccines and Immunotherapeutics Instructor: Dr. Anne S. De Groot, M.D. Days & Times: Wed. 5:00 p.m. -7:45 p.m. Meeting Dates: 1/25/2010 – 5/3/2010 Location: University of Rhode Island, Providence Campus (Shepard Building, Room 302) Address: 80 Washington Street, Providence RI Prerequisites: graduate standing and permission of chairperson. For more information: URI Course Catalog URI E-Campus Course ...

biotech and the “knowledge economy” Can Higher Ed Boost Biotech Start-Ups In RI? Providence officials are expected to unveil details of a plan next month to turn part of downtown into a hub for biotechnology and small start-up companies. WRNI education reporter Elisabeth Harrison looks at a shift at colleges and universities that may help strengthen the ...

biotech and the “knowledge economy” Can Higher Ed Boost Biotech Start-Ups In RI? Providence officials are expected to unveil details of a plan next month to turn part of downtown into a hub for biotechnology and small start-up companies. WRNI education reporter Elisabeth Harrison looks at a shift at colleges and universities that may help strengthen the ...

The Bottom Line: Rebranding a City 19 August 2009 David N Cicilline, Mayor of Providence, Rhode Island in the US ‘Providence is fast becoming a hot-bed for young social entrepreneurs, those creative individuals who take an innovative, untested idea for positive social change and develop it using entrepreneurial principles’ How one city is using social enterprise to turn around ...

Read the original MHT article By Brendan Lynch The University of Rhode Island reports researcher Annie DeGroot has landed a $13 million grant from the National Institutes of Health to develop a multidisciplinary program to develop vaccines for infectious diseases. The research is being led by DeGroot, the director of the school’s Institute for Immunology and Informatics, and ...

Read the original Providence Business News article By PBN Staff PROVIDENCE – Prominent local researcher and University of Rhode Island professor Dr. Anne S. De Groot has been awarded a $13 million research grant from the National Institutes of Health. It is the second large NIH grant awarded to URI researchers in recent months. In May, a pharmacy ...

Read the original article in the Providence Journal By C. Eugene Emery Jr. PROVIDENCE — Dr. Annie De Groot and her colleagues think they have a better way of speeding the development of vaccines against Lyme disease, hepatitis and stomach cancer. The federal government apparently believes their ideas are worth a ...

Simulation tools used to train next generation of scientific researchers PROVIDENCE, R.I. – July 28, 2009 University of Rhode Island Professor Annie De Groot has been awarded a $13 million grant from the National Institutes of Health to pioneer the development and application of an integrated gene-to-vaccine program targeting emerging infectious diseases.  It is the second multi-million ...

EpiVax is proud to be presenting our research findings at numerous conferences in the coming months, including: Strategies for Engineered Negligible Senescence (SENS4) 3rd Annual Therapeutic Monoclonal Antibody Discovery Immunogenicity Testing: Clinical and Regulatory Strategy for Biopharmaceuticals Immunogenicity Summit Three oral and two poster presentations at 2nd European Congress of Immunology